These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15285277)

  • 1. The effect of osteopathic manipulative treatment on immune response to the influenza vaccine in nursing homes residents: a pilot study.
    Noll DR; Degenhardt BF; Stuart MK; Werden S; McGovern RJ; Johnson JC
    Altern Ther Health Med; 2004; 10(4):74-6. PubMed ID: 15285277
    [No Abstract]   [Full Text] [Related]  

  • 2. [Vaccination against influenza in the elderly. Experience with adjuvant vaccines].
    Baldo V; Menegon T; Buoro S; Scalici C; Vesco A; Perale S; Boato W; Carletti M; Bonello C; Dalla Costa D; Trivello R
    Ann Ig; 1999; 11(5):369-74. PubMed ID: 10596424
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunogenicity and protective efficacy of influenza vaccination.
    Hannoun C; Megas F; Piercy J
    Virus Res; 2004 Jul; 103(1-2):133-8. PubMed ID: 15163501
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunogenicity and safety of domestic slit influenza vaccine].
    Zhu XJ; Zhang ZL; Li H; Su X; Guo XH; Chen W; Kou M; Duan WP
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jul; 25(7):644. PubMed ID: 15308057
    [No Abstract]   [Full Text] [Related]  

  • 5. Psychosocial factors and the response to influenza vaccination in older adults.
    Moynihan JA; Larson MR; Treanor J; Duberstein PR; Power A; Shore B; Ader R
    Psychosom Med; 2004; 66(6):950-3. PubMed ID: 15564363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Influenza epidemic in a nursing home caused by a virus not included in the vaccine].
    Beyer WE; Bakker G; van Beek R; Masurel N
    Ned Tijdschr Geneeskd; 1993 Sep; 137(39):1973-7. PubMed ID: 8413706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with a DNA chimeric molecule encoding a hemagglutinin peptide and a scFv CD21-specific antibody fragment induces long-lasting IgM and CTL responses to influenza virus.
    Ivanovska N; Tchorbanov A; Prechl J; Maximova V; Voynova E; Vassilev TL
    Vaccine; 2006 Mar; 24(11):1830-7. PubMed ID: 16289708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection bias in evaluating of influenza vaccine effectiveness: a lesson from an observational study of elderly nursing home residents.
    Fukushima W; Hayashi Y; Mizuno Y; Suzuki K; Kase T; Ohfuji S; Fujieda M; Maeda A; Hirota Y
    Vaccine; 2008 Nov; 26(50):6466-9. PubMed ID: 18582520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of vaccine against medical consultation due to laboratory-confirmed influenza: results from a sentinel physician pilot project in British Columbia, 2004-2005.
    Can Commun Dis Rep; 2005 Sep; 31(18):181-91. PubMed ID: 16669132
    [No Abstract]   [Full Text] [Related]  

  • 10. A fused gene of nucleoprotein (NP) and herpes simplex virus genes (VP22) induces highly protective immunity against different subtypes of influenza virus.
    Saha S; Yoshida S; Ohba K; Matsui K; Matsuda T; Takeshita F; Umeda K; Tamura Y; Okuda K; Klinman D; Xin KQ; Okuda K
    Virology; 2006 Oct; 354(1):48-57. PubMed ID: 16945400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase I clinical trial of a PER.C6 cell grown influenza H7 virus vaccine.
    Cox RJ; Madhun AS; Hauge S; Sjursen H; Major D; Kuhne M; Höschler K; Saville M; Vogel FR; Barclay W; Donatelli I; Zambon M; Wood J; Haaheim LR
    Vaccine; 2009 Mar; 27(13):1889-97. PubMed ID: 19368768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunology. Flu antibodies stir new hope for treatment, vaccine.
    Leslie M
    Science; 2009 Feb; 323(5918):1160. PubMed ID: 19251602
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuraminidase antibody response to inactivated influenza virus vaccine following intranasal and intramuscular vaccination.
    Muhamed G; Greenbaum E; Zakay-Rones Z
    Isr Med Assoc J; 2006 Mar; 8(3):155-8. PubMed ID: 16599048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of sublingual administration of interferon-alpha on the immune response to influenza vaccination in institutionalized elderly individuals.
    Launay O; Grabar S; Bloch F; Desaint C; Jegou D; Lallemand C; Erickson R; Lebon P; Tovey MG
    Vaccine; 2008 Jul; 26(32):4073-9. PubMed ID: 18602725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The safety and efficacy of dose-sparing intradermal administration of influenza vaccine in human immunodeficiency virus-positive patients.
    Khanlou H; Sanchez S; Babaie M; Chien C; Hamwi G; Ricaurte JC; Stein T; Bhatti L; Denouden P; Farthing C
    Arch Intern Med; 2006 Jul; 166(13):1417. PubMed ID: 16832008
    [No Abstract]   [Full Text] [Related]  

  • 16. Benefits of increasing the dose of influenza vaccine in residents of long-term care facilities: a randomized placebo-controlled trial.
    Cools HJ; Gussekloo J; Remmerswaal JE; Remarque EJ; Kroes AC
    J Med Virol; 2009 May; 81(5):908-14. PubMed ID: 19319953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of a standard trivalent influenza vaccine in patients on long-term hemodialysis: an open-label trial.
    Scharpé J; Peetermans WE; Vanwalleghem J; Maes B; Bammens B; Claes K; Osterhaus AD; Vanrenterghem Y; Evenepoel P
    Am J Kidney Dis; 2009 Jul; 54(1):77-85. PubMed ID: 19339089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An influenza A/H3 outbreak during the 2004/2005 winter in elderly vaccinated people living in a nursing home.
    Iorio AM; Neri M; Lepri E; Camilloni B; Basileo M; Sigismondi N; Fabiani C; Calzoletti L; Puzelli S; Donatelli I
    Vaccine; 2006 Nov; 24(44-46):6615-9. PubMed ID: 16828941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal DNA vaccine for influenza is immunogenic in humans.
    Drape RJ; Macklin MD; Barr LJ; Jones S; Haynes JR; Dean HJ
    Vaccine; 2006 May; 24(21):4475-81. PubMed ID: 16150518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and tolerability of inactivated flu vaccine in high risk and healthy children.
    Avila Aguero ML; Soriano-Fallas A; Umaña-Sauma MA; Ulloa-Gutierrez R; Arnoux S
    Medicina (B Aires); 2007; 67(4):351-9. PubMed ID: 17891930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.